Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07684040 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of Combination Therapy in Patients With Resectable Liver Cancer

Study acronym: Archer
StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This is a prospective, single-arm clinical study designed to evaluate the efficacy and safety of an initial combination treatment strategy followed by surgery in patients with cancer. Eligible participants will receive combination therapy prior to surgical intervention. Patients who meet predefined surgical criteria will undergo hepatic resection. Following surgery, additional treatment may be administered according to the investigator's assessment. The primary objective is to evaluate time to treatment failure (TTF). Secondary objectives include evaluation of pathological response, resection outcomes, progression-related outcomes, survival outcomes, and safety.
Trial Details
NCT Number NCT07684040
Lead Sponsor Affiliated Hospital of Guangdong Medical University
Conditions
(from sponsor)		 Liver Cancer (Primary and Metastatic)
Related terms Liver Neoplasms, Neoplasm Metastasis
Enrollment 68 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov